A novel classification of lung cancer into molecular subtypes.

PloS One
Lisandra WestRavi Salgia

Abstract

The remarkably heterogeneous nature of lung cancer has become more apparent over the last decade. In general, advanced lung cancer is an aggressive malignancy with a poor prognosis. The discovery of multiple molecular mechanisms underlying the development, progression, and prognosis of lung cancer, however, has created new opportunities for targeted therapy and improved outcome. In this paper, we define "molecular subtypes" of lung cancer based on specific actionable genetic aberrations. Each subtype is associated with molecular tests that define the subtype and drugs that may potentially treat it. We hope this paper will be a useful guide to clinicians and researchers alike by assisting in therapy decision making and acting as a platform for further study. In this new era of cancer treatment, the 'one-size-fits-all' paradigm is being forcibly pushed aside-allowing for more effective, personalized oncologic care to emerge.

References

Aug 30, 1990·The New England Journal of Medicine·R J SlebosW J Mooi
Dec 1, 1990·The American Review of Respiratory Disease·S Rodenhuis, R J Slebos
Mar 1, 1989·Japanese Journal of Cancer Research : Gann·H TsudaM Terada
Oct 1, 1995·The Journal of Pathology·S X JiangT Kameya
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A BiroccioD Del Bufalo
Jul 26, 2000·The Journal of Biological Chemistry·J OkanoH Nakagawa
Aug 26, 2000·Cancer Genetics and Cytogenetics·B PrzybojewskaP Jalmuzna
Feb 7, 2001·Journal of the National Cancer Institute·A FernandezR D'Amato
Sep 26, 2001·Neoplasia : an International Journal for Oncology Research·Z DaiC Plass
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lewis R SilvermanJames F Holland
Jun 6, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Marco LucchiCarlo Alberto Angeletti
Sep 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angela IervolinoDonatella Del Bufalo
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fred R HirschWilbur A Franklin
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M RudinEverett E Vokes
Apr 13, 2004·Oncogene·Dick D Mosser, Richard I Morimoto
Apr 5, 2005·Cancer Research·James J ManfrediStuart A Aaronson
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 19, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mahmoud ToulanyH Peter Rodemann
Jan 19, 2006·The Journal of Investigative Dermatology·Vikas K GoelFrank G Haluska
Sep 9, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S G Sánchez-CejaS Gutiérrez-Castellanos
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takayuki KosakaTetsuya Mitsudomi
Jan 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cai-Hong YunMichael J Eck
Apr 2, 2008·Journal of the National Comprehensive Cancer Network : JNCCN·Charles M RudinD Neil Watkins
Apr 23, 2008·Current Protocols in Human Genetics·S A ForbesM R Stratton
May 15, 2008·Melanoma Research·Suhail K MithaniJoseph A Califano
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Khalid I Al-ShibliLill-Tove Busund
Sep 2, 2008·Cancer Research·Hiromasa YamamotoAdi F Gazdar
Jan 27, 2009·Cancer·Daisy Wing-Sze WongUNKNOWN University of Hong Kong Lung Cancer Study Group
Feb 27, 2009·Future Oncology·Margaret P Quinlan, Jeffrey Settleman

❮ Previous
Next ❯

Citations

Jan 22, 2014·Nature Reviews. Clinical Oncology·Jeff Shrager, Jay M Tenenbaum
Apr 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Terrick AndeyMandip Singh
Oct 17, 2014·Journal of Bronchology & Interventional Pulmonology·Mohamed K El-BadrawyAyman Z Elsamanoudy
Oct 1, 2014·Current Treatment Options in Oncology·Joanna Goździk-SpychalskaRodryg Ramlau
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahad A Sadiq, Ravi Salgia
Feb 11, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Zoltan LohinaiBalazs Hegedus
Jun 13, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Carolyn J ShiauMing-Sound Tsao
Aug 26, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Luara de Sousa MonteiroMarianna Vieira Sobral
Apr 17, 2014·Biochemical and Biophysical Research Communications·Peninah M WairaguYangsik Jeong
Jan 30, 2013·Cancer Biology & Therapy·Gorjan HrustanovicTrever G Bivona
Jul 28, 2013·SpringerPlus·Faezeh HosseinzadehBahram Goliaei
Apr 29, 2016·Expert Opinion on Emerging Drugs·Janaki SharmaHaiying Cheng
Jul 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward S KimRichard L Schilsky
Jan 20, 2017·Pathology International·Ping-Li SunHongwen Gao
Sep 16, 2015·Cancers·Vishal BoolellVinod Ganju
Aug 23, 2018·Journal of Cellular Biochemistry·Bai YuquanZhao Jinping
Dec 5, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jianfang ZengKeng Shen
Apr 24, 2013·Molecular Endocrinology·Isaac J Powell, Aliccia Bollig-Fischer
Aug 3, 2013·Virchows Archiv : an International Journal of Pathology·Ping-Li SunJin-Haeng Chung
Jan 15, 2015·Cellular Oncology (Dordrecht)·Cristina SantosRamon Salazar
Apr 24, 2020·Nature Reviews. Neurology·Joan MontanerAlejandro Bustamante
Feb 2, 2020·BMC Cancer·Roberto Ruiz-CorderoSinchita Roy-Chowdhuri
Jul 1, 2012·Personalized Medicine·Sameek Roychowdhury
Mar 17, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dickran KazandjianRichard Pazdur

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
GTPases
GTPase
xenograft
sumoylation
acetylation

Software Mentioned

VeriStrat
REOLYSIN

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.